76 related articles for article (PubMed ID: 8797352)
1. [Theoretical considerations of dose-rate effect for clinical application: a study of pulsed brachytherapy].
Shigematsu N; Ito H; Kubo A; Dokiya T
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jul; 56(8):595-8. PubMed ID: 8797352
[TBL] [Abstract][Full Text] [Related]
2. [Pitfalls of hyperfractionation: theoretical considerations of effect of repair time on late radiation damage].
Shigematsu N; Ito H; Kubo A; Dokiya T
Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Jul; 56(8):599-604. PubMed ID: 8797353
[TBL] [Abstract][Full Text] [Related]
3. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
4. Calculated and simulated effects of heterogeneous dose distributions in radiotherapy using the dose volume inhomogeneity corrected biological equivalent dose formula with special reference to prostate cancer.
Lennernäs B; Albertsson P; Edgren M; Nilsson S
Oncol Rep; 2007 Nov; 18(5):1299-303. PubMed ID: 17914588
[TBL] [Abstract][Full Text] [Related]
5. Radiobiological modelling of dose-gradient effects in low dose rate, high dose rate and pulsed brachytherapy.
Armpilia C; Dale RG; Sandilos P; Vlachos L
Phys Med Biol; 2006 Sep; 51(17):4399-411. PubMed ID: 16912389
[TBL] [Abstract][Full Text] [Related]
6. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
[TBL] [Abstract][Full Text] [Related]
7. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric quality endpoints for low-dose-rate prostate brachytherapy using biological effective dose (BED) vs. conventional dose.
Singh R; Al-Hallaq H; Pelizzari CA; Zagaja GP; Chen A; Jani AB
Med Dosim; 2003; 28(4):255-9. PubMed ID: 14684190
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
10. Optimization and it's influence on value of doses in HDR and PDR brachytherapy.
Skowronek J; Zwierzchowski G; Piotrowski T; Milecki P
Neoplasma; 2010; 57(4):369-76. PubMed ID: 20429630
[TBL] [Abstract][Full Text] [Related]
11. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
[TBL] [Abstract][Full Text] [Related]
12. Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations.
Dragun AE; Aguero EG; Harmon JF; Harper JL; Jenrette JM
Brachytherapy; 2005; 4(4):259-63. PubMed ID: 16344255
[TBL] [Abstract][Full Text] [Related]
13. Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans.
Jani AB; Hand CM; Lujan AE; Roeske JC; Zagaja GP; Vijayakumar S; Pelizzari CA
Med Dosim; 2004; 29(1):42-8. PubMed ID: 15023392
[TBL] [Abstract][Full Text] [Related]
14. Values of biologically equivalent doses in healthy tissues: comparison of PDR and HDR brachytherapy techniques.
Skowronek J; Malicki J; Piotrowski T
Brachytherapy; 2010; 9(2):165-70. PubMed ID: 19879813
[TBL] [Abstract][Full Text] [Related]
15. Application of the linear-quadratic model to combined modality radiotherapy.
Bodey RK; Evans PM; Flux GD
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):228-41. PubMed ID: 15093920
[TBL] [Abstract][Full Text] [Related]
16. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
17. Biologic comparison of partial breast irradiation protocols.
Rosenstein BS; Lymberis SC; Formenti SC
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1393-404. PubMed ID: 15590170
[TBL] [Abstract][Full Text] [Related]
18. Radical radiotherapy for invasive bladder cancer: What dose and fractionation schedule to choose?
Pos FJ; Hart G; Schneider C; Sminia P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1168-73. PubMed ID: 16376486
[TBL] [Abstract][Full Text] [Related]
19. Comparison of PDR brachytherapy and external beam radiation therapy in the case of breast cancer.
Teymournia L; Berger D; Kauer-Dorner D; Poljanc K; Seitz W; Aiginger H; Kirisits C
Phys Med Biol; 2009 Apr; 54(8):2585-95. PubMed ID: 19349657
[TBL] [Abstract][Full Text] [Related]
20. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial.
Roberts SA; Hendry JH; Swindell R; Wilkinson JM; Hunter RD
Radiother Oncol; 2004 Jan; 70(1):63-74. PubMed ID: 15036854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
